Literature DB >> 18369153

Iron depletion limits intracellular bacterial growth in macrophages.

Prasad N Paradkar1, Ivana De Domenico, Nina Durchfort, Irene Zohn, Jerry Kaplan, Diane McVey Ward.   

Abstract

Many intracellular pathogens infect macrophages and these pathogens require iron for growth. Here we demonstrate in vitro that the intracellular growth of Chlamydia psittaci, trachomatis, and Legionella pneumophila is regulated by the levels of intracellular iron. Macrophages that express cell surface ferroportin, the only known cellular iron exporter, limit the intracellular growth of these bacteria. Hepcidin is an antimicrobial peptide secreted by the liver in response to inflammation. Hepcidin binds to ferroportin mediating its internalization and degradation. Addition of hepcidin to infected macrophages enhanced the intracellular growth of these pathogens. Macrophages from flatiron mice, a strain heterozygous for a loss-of-function ferroportin mutation, showed enhanced intracellular bacterial growth independent of the presence of exogenous hepcidin. Macrophages, from wild-type or flatiron mice, incubated with the oral iron chelator deferriprone or desferasirox showed reduced intracellular bacterial growth suggesting that these chelators might be therapeutic in chronic intracellular bacterial infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18369153      PMCID: PMC2481528          DOI: 10.1182/blood-2007-12-126854

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  37 in total

1.  Exploitation of macrophages as a replication niche by Legionella pneumophila.

Authors:  M S Swanson; I Sturgill-Koszycki
Journal:  Trends Microbiol       Date:  2000-02       Impact factor: 17.079

2.  A novel mammalian iron-regulated protein involved in intracellular iron metabolism.

Authors:  S Abboud; D J Haile
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

Review 3.  Iron chelation: new therapies.

Authors:  R Galanello
Journal:  Semin Hematol       Date:  2001-01       Impact factor: 3.851

4.  Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein.

Authors:  Elizabeta Nemeth; Erika V Valore; Mary Territo; Gary Schiller; Alan Lichtenstein; Tomas Ganz
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

5.  Lower respiratory tract iron burden is increased in association with cigarette smoking.

Authors:  A B Thompson; T Bohling; A Heires; J Linder; S I Rennard
Journal:  J Lab Clin Med       Date:  1991-06

6.  Severe iron deficiency anemia in transgenic mice expressing liver hepcidin.

Authors:  Gaël Nicolas; Myriam Bennoun; Arlette Porteu; Sandrine Mativet; Carole Beaumont; Bernard Grandchamp; Mario Sirito; Michèle Sawadogo; Axel Kahn; Sophie Vaulont
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

Review 7.  Hemochromatosis and the enigma of misplaced iron: implications for infectious disease and survival.

Authors:  Sharon Moalem; Eugene D Weinberg; Maire E Percy
Journal:  Biometals       Date:  2004-04       Impact factor: 2.949

8.  Dysregulation of ferroportin 1 interferes with spleen organogenesis in polycythaemia mice.

Authors:  Henry Mok; Miriam Mendoza; Josef T Prchal; Péter Balogh; Armin Schumacher
Journal:  Development       Date:  2004-09-01       Impact factor: 6.868

Review 9.  The ferroportin disease.

Authors:  Antonello Pietrangelo
Journal:  Blood Cells Mol Dis       Date:  2004 Jan-Feb       Impact factor: 3.039

10.  Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease.

Authors:  David A Weinstein; Cindy N Roy; Mark D Fleming; Massimo F Loda; Joseph I Wolfsdorf; Nancy C Andrews
Journal:  Blood       Date:  2002-06-28       Impact factor: 22.113

View more
  93 in total

Review 1.  Iron homeostasis and the inflammatory response.

Authors:  Marianne Wessling-Resnick
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

Review 2.  Iron and immunity: immunological consequences of iron deficiency and overload.

Authors:  Bobby J Cherayil
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-09-28       Impact factor: 4.291

3.  Rescuing iron-overloaded macrophages by conservative relocation of the accumulated metal.

Authors:  Yang-Sung Sohn; Anna-Maria Mitterstiller; William Breuer; Guenter Weiss; Z Ioav Cabantchik
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

4.  Inverse agonist of estrogen-related receptor γ controls Salmonella typhimurium infection by modulating host iron homeostasis.

Authors:  Don-Kyu Kim; Jae-Ho Jeong; Ji-Min Lee; Kwang Soo Kim; Seung-Hwan Park; Yong Deuk Kim; Minseob Koh; Minsang Shin; Yoon Seok Jung; Hyung-Seok Kim; Tae-Hoon Lee; Byung-Chul Oh; Jae Il Kim; Hwan Tae Park; Won-Il Jeong; Chul-Ho Lee; Seung Bum Park; Jung-Joon Min; Sook-In Jung; Seok-Yong Choi; Hyon E Choy; Hueng-Sik Choi
Journal:  Nat Med       Date:  2014-03-23       Impact factor: 53.440

5.  Suppression of iron-regulatory hepcidin by vitamin D.

Authors:  Justine Bacchetta; Joshua J Zaritsky; Jessica L Sea; Rene F Chun; Thomas S Lisse; Kathryn Zavala; Anjali Nayak; Katherine Wesseling-Perry; Mark Westerman; Bruce W Hollis; Isidro B Salusky; Martin Hewison
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

6.  Clinical potential of C-reactive protein and procalcitonin serum concentrations to guide differential diagnosis and clinical management of pneumococcal and Legionella pneumonia.

Authors:  Rosa Bellmann-Weiler; Mathias Ausserwinkler; Katharina Kurz; Igor Theurl; Guenter Weiss
Journal:  J Clin Microbiol       Date:  2010-03-10       Impact factor: 5.948

7.  Modulation of iron homeostasis in macrophages by bacterial intracellular pathogens.

Authors:  Xin Pan; Batcha Tamilselvam; Eric J Hansen; Simon Daefler
Journal:  BMC Microbiol       Date:  2010-02-25       Impact factor: 3.605

Review 8.  Iron in innate immunity: starve the invaders.

Authors:  Tomas Ganz
Journal:  Curr Opin Immunol       Date:  2009-02-21       Impact factor: 7.486

9.  Identification of Eltrombopag as a Repurposing Drug Against Staphylococcus epidermidis and its Biofilms.

Authors:  Juan Zhu; Pengfei She; Juhua Fu; Canhui Peng; Yong Wu
Journal:  Curr Microbiol       Date:  2021-02-21       Impact factor: 2.188

10.  Time-course analysis of serum hepcidin, iron and cytokines in a C282Y homozygous patient with Schnitzler's syndrome treated with IL-1 receptor antagonist.

Authors:  Marcel van Deuren; Joyce J C Kroot; Dorine W Swinkels
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.